AVTE: Aerovate Therapeutics, Inc Price to Sales

Symbol and logo of brand Aerovate Therapeutics Inc. (AVTE)

Strong confidence from pulmonologists transforms Aerovate Therapeutics (AVTE) into a scientific visionary within the industry. The company develops inhalation therapies for patients with rare lung pathologies. This P/S ratio chart illustrates the asset's market valuation, where marks a new level. The business's monopoly status is secured by unique patented drug delivery systems that guarantee stable sales.

AVTE: Aerovate Therapeutics, Inc Market Cap to Revenue 07/04/2022 - 11/17/2026

Analytical breakdowns for Aerovate Therapeutics Inc. (AVTE)

Fundamental company analysis:Aerovate Therapeutics, Inc., AVTE
Finished products of Aerovate Therapeutics, Inc.

The P/S multiple relates the market capitalization of Aerovate Therapeutics (AVTE) to its total annual revenue, allowing for the determination of the extent to which business revenues are undervalued during periods of market pessimism. By analyzing the industry-average P/S of the company, an investor can assess the potential for share price growth, provided that low-cost-to-synthesize heart and lung therapies are successfully launched on the global market.